| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $42.8M | +65.3% |
| R&D Expense | $41.8M | -21.1% |
| SG&A Expense | $16.9M | +2.8% |
| Operating Income | -$29.8M | +31.6% |
| Pre-tax Income | -$24.5M | +26.2% |
| Income Tax | $0 | — |
| Net Income | -$24.5M | +26.2% |
| EPS (Basic) | -$0.27 | +40.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.4M | -55.0% |
| Short-term Investments | $9.0M | -56.3% |
| Accounts Receivable | $572K | -90.2% |
| Current Assets | $38.7M | -47.3% |
| Total Assets | $38.7M | -59.5% |
| Current Liabilities | $11.9M | -67.4% |
| Total Liabilities | $11.9M | -82.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$53.8M | +10.2% |
| Capital Expenditures | $171K | -83.6% |
| Investing Cash Flow | $12.0M | +156.5% |
| Financing Cash Flow | $19.8M | +174.4% |
| Free Cash Flow | -$54.0M | +11.5% |
| Stockholders' Equity |
| $26.8M |
| -4.2% |